Efficacy and Safety of Remacemide versus Carbamazepine in Newly Diagnosed Epilepsy: Comparison by Sequential Analysis
- 1 April 2002
- journal article
- Published by Elsevier in Epilepsy & Behavior
- Vol. 3 (2) , 140-146
- https://doi.org/10.1006/ebeh.2002.0337
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Effectiveness of First Antiepileptic DrugEpilepsia, 2001
- A placebo-controlled, double-blind cross-over trial of adjunctive one month remacemide hydrochloride treatment in patients with refractory epilepsySeizure, 2000
- Management of epilepsy in adolescents and adultsThe Lancet, 2000
- Remacemide: current status and clinical applicationsExpert Opinion on Investigational Drugs, 2000
- Early Identification of Refractory EpilepsyNew England Journal of Medicine, 2000
- Safety and efficacy of vigabatrin and carbamazepine in ne wly diagnosed epilepsy: a multicentre randomised double-blind studyThe Lancet, 1999
- A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizuresNeurology, 1998
- Antiepileptic DrugsNew England Journal of Medicine, 1996
- Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsyThe Lancet, 1995
- Proposal for Revised Clinical and Electroencephalographic Classification of Epileptic SeizuresEpilepsia, 1981